These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 34202794)
1. Mesoporous Silica Particles as Drug Delivery Systems-The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes. Trzeciak K; Chotera-Ouda A; Bak-Sypien II; Potrzebowski MJ Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34202794 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Drug with Good Glass-Forming Ability Loaded Mesoporous Silica Nanoparticles and Its Impact Toward in vitro and in vivo Studies. Budiman A; Anastasya G; Handini AL; Lestari IN; Subra L; Aulifa DL Int J Nanomedicine; 2024; 19():2199-2225. PubMed ID: 38465205 [TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles in target drug delivery system: A review. Bharti C; Nagaich U; Pal AK; Gulati N Int J Pharm Investig; 2015; 5(3):124-33. PubMed ID: 26258053 [TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Li Z; Zhang Y; Feng N Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075 [TBL] [Abstract][Full Text] [Related]
5. Smart Mesoporous Silica Nanoparticles for Protein Delivery. Liu HJ; Xu P Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 30986952 [TBL] [Abstract][Full Text] [Related]
6. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer. Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106 [TBL] [Abstract][Full Text] [Related]
7. Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy. Küçüktürkmen B; Rosenholm JM Adv Exp Med Biol; 2021; 1295():99-120. PubMed ID: 33543457 [TBL] [Abstract][Full Text] [Related]
8. Silica-based mesoporous nanoparticles for controlled drug delivery. Kwon S; Singh RK; Perez RA; Abou Neel EA; Kim HW; Chrzanowski W J Tissue Eng; 2013; 4():2041731413503357. PubMed ID: 24020012 [TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review. Tella JO; Adekoya JA; Ajanaku KO R Soc Open Sci; 2022 Jun; 9(6):220013. PubMed ID: 35706676 [TBL] [Abstract][Full Text] [Related]
10. Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy. Khaliq NU; Lee J; Kim J; Kim Y; Yu S; Kim J; Kim S; Sung D; Kim H Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242674 [TBL] [Abstract][Full Text] [Related]
11. Functionalization of mesoporous silica nanoparticles for targeting, biocompatibility, combined cancer therapies and theragnosis. Kuthati Y; Sung PJ; Weng CF; Mou CY; Lee CH J Nanosci Nanotechnol; 2013 Apr; 13(4):2399-430. PubMed ID: 23763117 [TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology. Huang R; Shen YW; Guan YY; Jiang YX; Wu Y; Rahman K; Zhang LJ; Liu HJ; Luan X Acta Biomater; 2020 Oct; 116():1-15. PubMed ID: 32911102 [TBL] [Abstract][Full Text] [Related]
13. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Li T; Geng T; Md A; Banerjee P; Wang B Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109 [TBL] [Abstract][Full Text] [Related]
14. Targeted Mesoporous Silica Nanocarriers in Oncology. Baeza A; Vallet-Regi M Curr Drug Targets; 2018 Feb; 19(3):213-224. PubMed ID: 27262488 [TBL] [Abstract][Full Text] [Related]
16. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents. Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791 [TBL] [Abstract][Full Text] [Related]
17. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment. Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079 [TBL] [Abstract][Full Text] [Related]
18. An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine. Rastegari E; Hsiao YJ; Lai WY; Lai YH; Yang TC; Chen SJ; Huang PI; Chiou SH; Mou CY; Chien Y Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371758 [TBL] [Abstract][Full Text] [Related]
19. Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy. AbouAitah K; Lojkowski W Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33499150 [TBL] [Abstract][Full Text] [Related]
20. Effect of Shape on Mesoporous Silica Nanoparticles for Oral Delivery of Indomethacin. Zhang W; Zheng N; Chen L; Xie L; Cui M; Li S; Xu L Pharmaceutics; 2018 Dec; 11(1):. PubMed ID: 30583601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]